Tech Company Financing Transactions
Ketryx Funding Round
Ketryx closed a $39 million Series B financing round on 9/4/2025. Investors included Transformation Capital, E14 Fund and Lightspeed Venture Partners.
Transaction Overview
Company Name
Announced On
9/4/2025
Transaction Type
Venture Equity
Amount
$39,000,000
Round
Series B
Investors
Transformation Capital (Lead Investor) (Vinay Shah)
Proceeds Purpose
The company intends to use ether funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
240 Elm St 301
Somerville, MA 02144
USA
Somerville, MA 02144
USA
Phone
Website
Email Address
Overview
Ketryx enables life sciences teams to use their preferred DevTools and automation to generate evidence, real-time traceability, and prevent process deviation. The process for complying with FDA regulations is broken. Today, MedTech teams spend the bulk of their time on meeting regulatory requirements rather than driving product impact. We knew there was a better way to move at the expected speed of software development while making safe and reliable software patients can trust.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Erez Kaminski
Chief Information Officer
John Koontz
Chief Technical Officer
Jan Pöschko
VP - Marketing
Brian Katzman
Browse more venture capital transactions:
Prev: 9/4/2025: Orchard Robotics venture capital transaction
Next: 9/4/2025: Mojo Vision venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs